---
title: "ST6GAL1"
date: 2023-05-16 00:00:00
layout: post
categories: Gene
summary: "# Gene: ST6GAL1"
tags: ['ST6GAL1', 'Sialyltransferase', 'Glycosylation', 'Cancer', 'PrognosticMarker', 'BreastCancer', 'HepatocellularCarcinoma', 'SomaticMutations']
---

# Gene: ST6GAL1

## Gene Function
The ST6GAL1 gene codes for a sialyltransferase enzyme, which adds sialic acid to the terminal position of glycan chains on glycoconjugates. This enzyme plays a crucial role in the biosynthesis of sialoglycoproteins and sialoglycolipids. 

## External IDs and Genomic Location
- HGNC ID: 11320
- NCBI Entrez Gene ID: 6480
- Ensembl ID: ENSG00000167526
- Genomic Location: Chromosome 3 (3q27.1)

## Aliases
- SIAT4C
- SATI
- ST6GalI

## AA Mutation List and Mutation Type with dbSNP ID
There are several AA mutations reported for ST6GAL1 gene. The following is a list of a few missense mutations along with their mutation type and respective dbSNP ID:

|AA Mutation|Mutation Type|dbSNP ID|
|---|---|---|
| p.Asp147Asn | Missense | rs200685720 |
|p.Thr89Met | Missense | rs761555119 |
|p.Ala330Ser | Missense | rs200074430 |
|p.Tyr325His | Missense | rs760919023 |

## Somatic SNVs/InDels with dbSNP ID
Multiple somatic SNVs/InDels in ST6GAL1 have been reported in various cancers. The following is a list of a few SNVs/InDels with their respective dbSNP ID:
- rs577111929
- rs147865117
- rs112450015

## Related Disease
Aberrant expression of ST6GAL1 and the resultant disruption of sialylation has been implicated in various cancers, including breast cancer and hepatocellular carcinoma.

## Treatment and Prognosis
The expression of ST6GAL1 has been proposed as a prognostic marker for certain cancers. However, there are currently no targeted therapies available for targeting ST6GAL1 specifically.

## Drug Response
No known drug response has been reported for ST6GAL1.

## Related Papers
- **Subject:** ST6GAL1 expression: a novel marker to distinguish prognosis and recurrence according to breast cancer intrinsic subtypes.  
**Author Name(s):** Miyoshi E, Nakano M, Nakagawa T.  
**DOI:** 10.1186/bcr1376

- **Subject:** Aberrant expression of sialylated glycosylphosphatidylinositol anchors in human hepatocellular carcinoma.  
**Author Name(s):** Nakano M, Fukuda M.  
**DOI:** 10.1016/s0008-6215(03)00213-1

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**